IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i11p6422-d823602.html
   My bibliography  Save this article

Level of Serum Fetuin-A Correlates with Heart Rate in Obstructive Sleep Apnea Patients without Metabolic and Cardiovascular Comorbidities

Author

Listed:
  • Elżbieta Reichert

    (Individual Specialist Medical Practice, Włostowicka 293 C St., 24-100 Puławy, Poland)

  • Jerzy Mosiewicz

    (Department of Internal Diseases, Medical University of Lublin, Staszica 16 St., 20-081 Lublin, Poland)

  • Wojciech Myśliński

    (Department of Internal Diseases, Medical University of Lublin, Staszica 16 St., 20-081 Lublin, Poland)

  • Andrzej Jaroszyński

    (Collegium Medicum, Jan Kochanowski University in Kielce, 23-517 Kielce, Poland)

  • Agata Stanek

    (Department and Clinic of Internal Medicine, Angiology and Physical Medicine, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Batorego 15 St., 41-902 Bytom, Poland)

  • Klaudia Brożyna-Tkaczyk

    (Department of Internal Diseases, 1st Public University Hospital No. 1 in Lublin, Staszica 16 St., 20-081 Lublin, Poland)

  • Barbara Madejska-Mosiewicz

    (Department of Internal Diseases, 1st Public University Hospital No. 1 in Lublin, Staszica 16 St., 20-081 Lublin, Poland)

Abstract

Obstructive sleep apnea (OSA) is the most common type of sleep-induced breathing disorder in the adult population and significantly affects the condition of the cardiovascular system. Fetuin-A (Fet-A) is a hepato- and adipokine, which prevents vessel calcification, and its level correlates with atherogenesis and metabolic disorders. The associations of cardiovascular diseases (CVD) both with OSA, which increases CVD risk, and Fet-A, which prevents CVD, justify the question of their mutual interactions in patients with OSA. Therefore, we sought to analyze Fet-A as an early biomarker of CVD risk in OSA patients without metabolic and cardiovascular comorbidities except for properly controlled arterial hypertension. We have found that in these patients, OSA does not appear to directly affect Fet-A levels. However, high Fet-A levels were more common in the group of patients with OSA, and the hypopnea index was significantly higher among subjects with the highest Fet-A levels. The level of Fet-A in OSA patients positively correlates with pulse rate, and it does not correlate with pulse pressure in this group unlike in the control group, where such a relationship exists. To our best knowledge, this is the first study to analyze this relationship in OSA patients without any significant cardiovascular comorbidities.

Suggested Citation

  • Elżbieta Reichert & Jerzy Mosiewicz & Wojciech Myśliński & Andrzej Jaroszyński & Agata Stanek & Klaudia Brożyna-Tkaczyk & Barbara Madejska-Mosiewicz, 2022. "Level of Serum Fetuin-A Correlates with Heart Rate in Obstructive Sleep Apnea Patients without Metabolic and Cardiovascular Comorbidities," IJERPH, MDPI, vol. 19(11), pages 1-11, May.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:11:p:6422-:d:823602
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/11/6422/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/11/6422/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Xiongfeng Pan & Atipatsa C. Kaminga & Jihua Chen & Miyang Luo & Jiayou Luo, 2020. "Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression," IJERPH, MDPI, vol. 17(8), pages 1-16, April.
    2. Xiongfeng Pan & Shi Wu Wen & Prince L Bestman & Atipatsa C Kaminga & Kwabena Acheampong & Aizhong Liu, 2020. "Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 15(3), pages 1-16, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Xiongfeng Pan & Atipatsa C. Kaminga & Jihua Chen & Miyang Luo & Jiayou Luo, 2020. "Fetuin-A and Fetuin-B in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression," IJERPH, MDPI, vol. 17(8), pages 1-16, April.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:11:p:6422-:d:823602. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.